Thank you sir. I am a nephrology resident from Bangladesh (in our country, after completing 2 years residency in medicine & then 3 years residency in nephrology; one becomes a nephrologist). Your presentations are invaluable to me, these are helping residents/students like me all over the globe.
Tahmeed Hussain I also did my md now I secured rank for nephro so I must say I also enjoy the power of technology that we can access such type of superspeciality professional knowledge
It is very valuable your description of each slide - I have learned so much and I became very interested in renal pathology since I started to follow your presentations.
New format although I prefer the involvement of fellow and histopathologist which really brings out lots of thought processes. But again another excellent video, I thoroughly enjoyed it!!
In response to Alexander's question: It becomes important because diseases like cast nephropathy could also be treated with plasma exchange to reduce the light chain burden. Additionally, the presence of renal amyloid impacts prognosis, and may also impact whether or not they would proceed to stem cell transplant.
Ok. Thanks. I agree. It is just that in terms of a MM with nephrotic syndrome, cast nephropathy is unlikely; but i´m in total agreement for the determination of a treatment strategy and prognosis. Interesting case and discussion. Thanks you again!
The question i have is, for what purpose we should make a renal biopsy in a patient with MM (even if it is IgM) with nephrotic syndrome if it is possible that the result would be a secondary renal amyloidosis deposition disease (AA) and the treatment would be the same as for the IgM MM?
Thank you sir. I am a nephrology resident
from Bangladesh (in our country, after completing 2 years residency in medicine & then 3 years residency in nephrology; one becomes a nephrologist).
Your presentations are invaluable to me, these are helping residents/students like me all over the globe.
Tahmeed Hussain I also did my md now I secured rank for nephro so I must say I also enjoy the power of technology that we can access such type of superspeciality professional knowledge
Excellent series. You put a real good and sincere effort to help the fellows and residents. Thank you and God bless
What a great talk...beat explanation ever
Best
Great educational videos, thanks for sharing 👍
It is very valuable your description of each slide - I have learned so much and I became very interested in renal pathology since I started to follow your presentations.
New format although I prefer the involvement of fellow and histopathologist which really brings out lots of thought processes.
But again another excellent video, I thoroughly enjoyed it!!
+Mohammad Qureshi Thank you, I hope to bring back the discussion next time with the fellow and nephropathologist!
excellent talk.complete n crisp
In response to Alexander's question:
It becomes important because diseases like cast nephropathy could also be treated with plasma exchange to reduce the light chain burden. Additionally, the presence of renal amyloid impacts prognosis, and may also impact whether or not they would proceed to stem cell transplant.
Ok. Thanks. I agree. It is just that in terms of a MM with nephrotic syndrome, cast nephropathy is unlikely; but i´m in total agreement for the determination of a treatment strategy and prognosis. Interesting case and discussion. Thanks you again!
Very good cases describing
Excellent conference of Amiloid
Good 👍🏽
The question i have is, for what purpose we should make a renal biopsy in a patient with MM (even if it is IgM) with nephrotic syndrome if it is possible that the result would be a secondary renal amyloidosis deposition disease (AA) and the treatment would be the same as for the IgM MM?
What was that crescent. I mean crescent in an amyloid.